Intracellular localization of p53 tumor suppressor protein in γ- irradiated cells is cell cycle regulated and determined by the nucleus

Cancer Research

Volumn 57, Issue 23, 1997, Pages 5217-5220

  Komarova, Elena A ^a   Zelnick, Carolyn R ^b   Chin, Dot ^b   Zeremski, Marija ^a   Gleiberman, Anatoly S ^c   Bacus, Sarah S ^b   Gudkov, Andrei V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Advanced Cellular Diagnostics Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; PROTEIN P21; PROTEIN P53;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FUSION; CELL POPULATION; DNA CONTENT; DNA DAMAGE; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STABILITY; QUANTITATIVE DIAGNOSIS; SKIN FIBROBLAST;

BREAST NEOPLASMS; CELL CYCLE; CELL FUSION; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; FIBROSARCOMA; GAMMA RAYS; HUMANS; POLYETHYLENE GLYCOLS; SKIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030722533     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gottlieb, T. M., and Oren, M. p53 in growth control and neoplasia. Biochim. Biophys. Acta. 1287: 77-102, 1996.
2. Kinzler, K. W., and Vogelstein, B. Life (and death) in a malignant tumour. Nature (Lond.), 379: 19-20, 1996.
3. Norimura, T., Nomoto, S., Katsuki, M., Gondo, Y., and Kondo, S. p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med., 2: 577-580, 1996.
4. Komarova, E. A., Chernov, M. V., Franks, R., Wang, K., Armin, G., Zelnick, C. R., Chin, D. M., Bacus, S. S., Stark, G. R., and Gudkov, A. V. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo. EMBO J., 16: 1391-1400, 1997.
5. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. Mdm2 promotes the rapid degradation of p53. Nature (Lond.), 387: 296-299, 1997.
6. Kubbutat, M. H. G., Jones, S. N., and Vousden, K. H. Regulation of p53 stability by Mdm2. Nature (Lond.), 387: 299-303, 1997.
7. Jayaraman, L., Murthy, K. G., Zhu, C., Curran, T., Xanthoudakis, S., and Prives, C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev., 11: 558-570, 1997.
8. Gu, W., Shi, X-L., and Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature (Lond.), 387: 819-823, 1997.
9. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature (Lond.), 387: 823-827, 1997.
10. ING1 cooperates with p53 in cell growth control. Nature (Lond.), in press, 1997.
11. Meek, D. W. Post-translational modification of p53. Semin. Cancer Biol., 5: 203-210, 1994.
12. Middeler, G., Zerf, K., Jenovai, S., Thulig, A., Tschodrich-Rotter, M., Kubitscheck, U., and Peters, R. The tumor supressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene, 14: 1407-1417, 1997.
13. Dang, C. V., and Lee, W. M. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. J. Biol. Chem., 264: 18019-18023, 1989.
14. 1 checkpoint after DNA damage. Mol. Cell. Biol., 16: 1126-1137, 1996.
15. Shaulsky, G., Ben-Ze'ev, A., and Rotter, V. Subcellular distribution of the p53 protein during the cell cycle of BALB/c 3T3 cells. Oncogene, 5: 1707-1711, 1990.
16. David-Pfeuty, T., Chakrani, F., Ory, K., and Nouvian-Dooghe, Y. Cell cycle-dependent regulation of nuclear p53 traffic occurs in one subclass of human tumor cells and in untransformed cells. Cell Growth Differ., 7: 1211-1225, 1996.
17. Bacus, S. S., Gudkov, A. V., Zelnick, C. R., Chin, D., Stern, R., Stancovski, I., Ben-Baruch, N., Wen, D., Sela, M., and Yarden, Y. Neu differentiation factor (NDF/heregulin) induces expression of intercellular adhesion molecule 1 (ICAM-1): implication to mammary tumors. Cancer Res., 53: 5251-5261, 1993.
18. Waf1 pathway in cancer cells. Oncogene, 12: 2535-2547, 1996.
19. Goldman, S. C., Chen, C-Y., Lansing, T. J., Gilmer, T. M., and Kastan, M. B. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Am. J. Pathol., 148: 1381-1385, 1996.
20. Pariat, M., Carillo, S., Molinari, M., Salvat, C., Debussche, L., Bracco, L., Milner, J., and Piechaczyk, M. Proteolysis by calpains: a possible contribution to degradation of p53. Mol. Cell. Biol., 17: 2806-2815, 1997.
21. Ciechanover, A. The ubiquitin-proteasome proteolytic pathway. Cell, 79: 13-21, 1994.
22. Kubbutat, M. H., and Vousden, K. H. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell. Biol., 17: 460-468, 1997.
23. 1 to S-phase transition. Oncogene, 14: 255-263, 1997.
24. Maki, C., and Howley, P. M. Ubiquitination of p53 and p21 is differentially affected by Ionizing and UV radiation. Mol. Cell. Biol., 17: 355-363, 1997.
25. Zhang, H., Hannon, G. J., and Beach, D. p21-containing cyclin kinases exist in both active and inactive states. Cenes Dev., 8: 1750-1758, 1994.
26. LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., and Harlow, E. New functional activities for the p21 family of CDK inhibitors. Genes Dev., 11: 847-862, 1997.
27. Johnson, R. T., and Rao, P. N. Mammalian cell fusion: induction of premature chromosome condensation in interphase nuclei. Nature (Lond.), 226: 717-722, 1970.